Alectinib D8
| Product Name | Alectinib D8 |
|---|---|
| Alternate Names | Alectinib Stable Isotopes, Stable Isotopes of Alectinib |
| CAT No. | CS-CX-00065 |
| CAS No. | 1256585-15-5 |
| Category | Stable Isotopes |
| Stock | Enquire |
| Mol. Wt. | 490.67 g/mol |
| Mol. For. | C₃₀H₂₆D₈N₄O₂ |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Alectinib |
| Purity | 95% |
| Smileys | O=C1C(C2=CC=C(C#N)C=C2N3)=C3C(C)(C)C4=CC(N5CCC(N6C([2H])([2H])C([2H])([2H])OC([2H])([2H])C6([2H])[2H])CC5)=C(CC)C=C14 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Alectinib D8 is a deuterated form of Alectinib, a drug used in the treatment of non-small cell lung cancer (NSCLC). Alectinib D8 has the same chemical formula as Alectinib, but it contains eight deuterium atoms instead of hydrogen atoms. This makes it a useful tool for studying the pharmacokinetics and metabolism of Alectinib, as well as for improving the accuracy of pharmacokinetic studies.
Alectinib D8 works by inhibiting the activity of anaplastic lymphoma kinase (ALK), which is a protein that is overactive in some types of cancer cells. By blocking the activity of ALK, Alectinib D8 helps to slow or stop the growth of cancer cells in the body.
The chemical structure of Alectinib D8 consists of a pyridine ring, a pyrimidine ring, and a benzene ring. It has a molecular weight of 534.7 g/mol and a melting point of approximately 170-175°C.
Alectinib D8 is administered orally in capsule form, and the recommended dosage varies depending on the individual patient's needs. It is metabolized in the liver and excreted primarily in the feces.
Like all drugs, Alectinib D8 can cause side effects, including nausea, vomiting, diarrhea, fatigue, and muscle weakness. Patients taking Alectinib D8 should be closely monitored for any signs of adverse effects and should follow their doctor's instructions carefully.
Get an Instant Quote
Related Compounds
Alectinib M4 metabolite D4 | Alectinib D6 | Alectinib D5 |